SCHEMBL30307581

SCHEMBL30307581

CCSc1cc(=O)c2cccc(C(C)O)c2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 6/20 0.40
▸ CCNE2 O96020 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ CDK4 P11802 1/20 0.35
▸ CCNB1 P14635 1/20 0.35
▸ CCND1 P24385 1/20 0.35
▸ CCNE1 P24864 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ LOXL2 Q9Y4K0 2/20 0.35
▸ ELANE P08246 2/20 0.33
▸ MAOB P27338 1/20 0.32
▸ CSNK2A2 P19784 1/20 0.32
▸ CSNK2B P67870 1/20 0.32
▸ CSNK2A1 P68400 1/20 0.32
▸ CYP1A1 P04798 2/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP1B1 Q16678 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23887248 1.00 GPR35 (0.40) GPR35CCNE2CDK1CDK4CCNB1
SCHEMBL23887280 0.87 GPR35 (0.35) GPR35CCNE2CDK1CDK4CCNB1
SCHEMBL30064040 0.82 PIK3CA (0.39) CCNE2CDK1CDK4CCNB1CCND1
SCHEMBL23887051 0.82 PIK3CA (0.39) CCNE2CDK1CDK4CCNB1CCND1
SCHEMBL23886969 0.81 CCNE2 (0.35) GPR35CCNE2CDK1CDK4CCNB1
SCHEMBL30307588 0.81 CCNE2 (0.35) GPR35CCNE2CDK1CDK4CCNB1
SCHEMBL23887366 0.78 LOXL2 (0.54) GPR35CCNE2CDK1CDK4CCNB1
SCHEMBL30307518 0.78 PIK3CA (0.35) CCNE2CDK1CDK4CCNB1CCND1
SCHEMBL23887148 0.78 PIK3CA (0.35) CCNE2CDK1CDK4CCNB1CCND1
SCHEMBL23887035 0.77 PRKDC (0.42) GPR35CCNE2CDK1CDK4CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115956075-A Allosteric enone inhibitors of phosphoinositide 3-kinases (PI 3 ks) for the treatment of diseases associated with PI3K modulation 佩特拉制药公司 2023-04-11 — — CN disclosed
Send feedback